Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Invested Capital: 2009-2025

Historic Invested Capital for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $6.6 billion.

  • UNITED THERAPEUTICS's Invested Capital rose 1.37% to $6.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 1.37%. This contributed to the annual value of $6.7 billion for FY2024, which is 5.63% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Invested Capital of $6.6 billion as of Q3 2025, which was down 8.13% from $7.2 billion recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year Invested Capital high stood at $7.2 billion for Q2 2025, and its period low was $3.4 billion during Q1 2021.
  • Its 3-year average for Invested Capital is $6.3 billion, with a median of $6.4 billion in 2023.
  • Data for UNITED THERAPEUTICS's Invested Capital shows a peak YoY surged of 33.11% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Invested Capital stood at $4.0 billion in 2021, then rose by 21.16% to $4.8 billion in 2022, then surged by 33.11% to $6.4 billion in 2023, then increased by 5.63% to $6.7 billion in 2024, then grew by 1.37% to $6.6 billion in 2025.
  • Its Invested Capital was $6.6 billion in Q3 2025, compared to $7.2 billion in Q2 2025 and $7.0 billion in Q1 2025.